Phase 2a RSV Challenge Study Planned for Q3 2017
Healthcare
Mon, 24/04/2017 - 07:30
Wed, 19/04/2017 - 07:30
Edinburgh, UK, 19th April 2017 / Sciad Newswire / Synpromics Ltd, the leading synthetic promoter and gene control company
Mon, 10/04/2017 - 10:00
Expansion is Supported by four Broad Patents for Company’s Leap-In Transposase® Technology
Thu, 30/03/2017 - 16:00
London, UK and Washington D.C, USA, 30th March 2017 / Sciad Newswire / Oppilotech Ltd, a biopharmaceutical start-up compa
Thu, 30/03/2017 - 10:00
Cambridge, UK, 30th March 2017 / Sciad Newswire / Domainex Ltd, a privately-owned drug discovery services company, is ple
Thu, 16/03/2017 - 07:30
Edinburgh, UK, 16th March 2017 / Sciad Newswire / Synpromics Ltd, the leading synthetic promoter and gene control company
Wed, 15/03/2017 - 10:10
Moncton, Canada, 15th March 2017 / Sciad Newswire / The Atlantic Cancer Research Institute (ACRI) is pleased to announc
Wed, 01/03/2017 - 07:30
Cambridge, UK, 1st March 2017 / Sciad Newswire / Cypralis, a life sciences company focussed on the discovery of therapeutic
Tue, 28/02/2017 - 12:00
Hamburg, Germany, 27th February 2017 / Sciad Newswire / GAIA AG, a global pioneer in digital therapy, announced today that
Tue, 21/02/2017 - 07:30
Cleveland, UK, 21st February 2017 / Sciad Newswire / Cambridge Research Biochemicals® (CRB), a longstanding